Chittorgarh.com Logo
FREE Account Opening + No Clearing Fees + Rs 999 API
Loading...

Bhagiradha Chemicals Rights Issue 2022 FAQ's

Bhagiradha Chemicals Rights Issue 2022 Detail
Issue Open Apr 19, 2022
Issue Close May 4, 2022
Issue Size (Shares) 0.21 Crores
Issue Size (Amount) ₹83.84 Crores
Issue Price ₹400 per Share
Listing At BSE, NSE

Bhagiradha Chemicals Rights Issue 2022 Date & Price FAQs

Bhagiradha Chemicals Rights Issue 2022 Timetable

Last Date for credit of Rights EntitlementsApr 18, 2022
Last Date for renunciation of Rights EntitlementsApr 28, 2022
Issue Opening DateApr 19, 2022
Issue Closing DateMay 4, 2022
Allotment DateMay 10, 2022
Shares Credit DateMay 12, 2022
Listing DateMay 13, 2022

Sorry, the Application Form for Bhagiradha Chemicals Rights Issue 2022 is not available at this time.

Bhagiradha Chemicals Rights Issue 2022 price is set at ₹400 per Share. The Bhagiradha Chemicals Rights Issue 2022 opens on Apr 19, 2022, and closes on May 4, 2022, for the subscription.

The allotment of Bhagiradha Chemicals Rights Issue 2022 is expected to happen on or about May 10, 2022 as per the issue schedule.

Bhagiradha Chemicals Rights Issue 2022 listing date is May 13, 2022.

The credit of Bhagiradha Chemicals Rights Issue 2022 in Demat account is expected on or about May 12, 2022 as per the issue schedule.

The Net Proceeds from the Issue are proposed to be utilized by the Company for the following objects:

  1. Working capital requirement.
  2. Repayment/pre-payment, in full or part, of certain borrowings.
  3. General corporate purposes.

It is difficult to say at what price Bhagiradha Chemicals Rights Issue 2022 shares will list. The price depends on the demand and supply of company's shares on the day of listing.

Sorry, we do not provide rights issue's recommendations. But we share a lot of information about Bhagiradha Chemicals Rights Issue 2022 which could help you with questions like Bhagiradha Chemicals Rights Issue 2022 buy or not? Consider reading Bhagiradha Chemicals Rights Issue 2022 reviews and analysis from experts posted on rights issue detail page.

Comments

Add a public comment...